Eligo Bioscience
eligo.bioLocations
Île-de-France, France · Paris, France · Paris, France
industry
Biotechnology · Biotechnology Research · Health Care · Medical
Size
11 - 50 employees
Stage
Pre Seed
founded in
2014
Eligobiotics is a developer of antibiotics intended to treat microbiome precision and bacteria-associated diseases. The company's antibiotics combine the CRISPR/Cas system with engineered phage capsids to develop antimicrobials that are used to eradicate resistant pathogens or virulent bacteria within the human microbiome, enabling clients to get next-generation antimicrobials to treat diseases caused by superbugs.
Something looks off?Open jobs at Eligo Bioscience
On-site & Remote
Job function
Seniority
Salary